National Healthcare Properties, Inc. (NHP) Stock Price & Analysis
National Healthcare Properties, Inc. (NHP) closed at USD 14.7 on Wednesday, October 28, 2026, down 1.21% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 14.88; the Oct 28, 2026 session ranged USD 14.34–14.82 on volume of 1,779,872 shares. Market capitalization is $1.07B, with a 52-week range of USD 11.25–17.46 (NGM). Source: Nexqual, retrieved October 29, 2026 at 07:41 UTC.
Also available as compact Markdown for AI agents: nexqual.com/NHP.md
Key facts (NHP)
- Last four reported quarters (through Jun 30, 2026): revenue $344M, net income -$45.0M (-13.1% margin) (SEC filings).
- Analysts: None.
- Total return with dividends: 1Y +23.7% vs S&P 500 +13.6%; 5Y +15.5% vs S&P 500 +79.8%.
- Next earnings: 2026-11-04, EPS estimate USD —, revenue estimate $94.5M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (NHP)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $329M | $336M | $346M | $354M | $342M | $344M |
| Gross profit | $124M | $122M | $128M | $132M | $123M | — |
| Operating income | -$37.4M | -$31.5M | -$4.7M | -$124M | $3.3M | $11.0M |
| Net income | -$85.4M | -$79.6M | -$72.4M | -$190M | -$57.7M | -$45.0M |
| EPS (diluted) | -$0.82 | -$3.30 | -$3.04 | -$7.19 | -$2.51 | — |
| Gross margin | 37.5% | 36.4% | 37.0% | 37.4% | 36.0% | — |
| Operating margin | -11.4% | -9.4% | -1.4% | -34.9% | 1.0% | 3.2% |
| Net margin | -25.9% | -23.7% | -20.9% | -53.8% | -16.9% | -13.1% |
| Revenue growth | -13.7% | +2.0% | +3.0% | +2.3% | -3.3% | — |
| Cash + short-term investments | $59.7M | $53.7M | $46.4M | $21.7M | $57.6M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (NHP)
P/S 3.1x · P/B 1.0x · Earnings yield -4.20%
Analysts (NHP)
Consensus None.
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Wells Fargo | Target lowered | Overweight | $19 → $18 |
| 2026-10-13 | Raymond James | Initiated | Outperform | $20 |
| 2026-09-01 | Wells Fargo | Target raised | Overweight | $17 → $19 |
| 2026-08-20 | Baird | Target raised | Outperform | $17 → $18 |
| 2026-08-17 | RBC Capital | Target raised | Sector Perform | $15 → $17 |
| 2026-08-10 | Citizens | Target raised | Market Outperform | $18 → $21 |
| 2026-07-15 | Wells Fargo | Target raised | Overweight | $16 → $17 |
Total return (dividends reinvested) (NHP)
| 1Y (from 2026-04-22) | 5Y (from 2026-04-20) | |
|---|---|---|
| Total return | +23.7% | +15.5% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | — | — |
| Volatility (annualized) | 35.6% | 28.1% |
| Max drawdown | -13.7% (Aug 2026→Oct 2026) | -12.9% (Aug 2026→Oct 2026) |
NHP recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 27, 2026 | Schedule 13G/A | BlackRock, Inc.: 6.1% of shares, passive 5%+ holder (amended) |
| Oct 22, 2026 | 8-K | Change to shareholder rights; Other material event “In connection with the Conversion, the common stock was assigned CUSIP No. 42226B600. The CUSIP number previously assigned to the Class A common stock is no longer in use.” |
| Oct 7, 2026 | Schedule 13G/A | PRUDENTIAL FINANCIAL INC: 3.1% of shares, passive 5%+ holder (amended) |
| Oct 5, 2026 | 25-NSE | Removal from exchange listing |
| Sep 29, 2026 | 8-K | Entered a material agreement “Entry into a Material Agreement On September 25, 2026, certain termination rights of the purchaser terminated under the purchase and sale agreement (the "PSA"), dated as of July 15, 2026, as amended from time to time, by and among certain subsidiaries of National Healthcare Properties, Inc. (the "Company") and an unaffiliated third party to sell the Company's portfolio of 40 outpatient medical facilities for approximately $531 million (before transaction expenses, property operating prorations and capital…” |
| Sep 14, 2026 | 8-K | Director or executive officer change, or pay arrangement “On September 11, 2026, Edward M. Weil, Jr. notified National Healthcare Properties, Inc. (the "Company") of his decision to resign from the board of directors of the Company, effective as of September 11, 2026. Mr. Weil's decision was not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.” |
| Sep 10, 2026 | 8-K | Completed an acquisition or sale of assets “On September 10, 2026, National Healthcare Properties, Inc., a Maryland corporation (the "Company"), through certain subsidiaries (collectively, the "Sellers") of its operating partnership, National Healthcare Properties Operating Partnership, L.P., a Delaware limited partnership (the "OP"), consummated the closing of the first tranche of the previously announced sale of a portfolio of 86 outpatient medical facilities (the "Portfolio") to an unaffiliated third party (the "Buyer"), pursuant to that certain Purchase…” |
| Sep 3, 2026 | 25-NSE | Removal from exchange listing |
| Aug 14, 2026 | Schedule 13G | Alyeska Investment Group, L.P., Alyeska Fund GP, LLC: 5.8% of shares, passive 5%+ holder |
| Aug 14, 2026 | Schedule 13G | Rush Island Management LP, Rush Island Master, LP: 5.8% of shares, passive 5%+ holder |
| Aug 14, 2026 | Schedule 13G | passive 5%+ holder |
| Aug 13, 2026 | Schedule 13G | passive 5%+ holder |
| Aug 10, 2026 | Schedule 13G | passive 5%+ holder |
| Aug 6, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
NHP revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Seniors Housing Communities | $58.3M | 66.7% | +4.0% |
| OMF | $29.2M | 33.3% | -0.2% |
| Total revenue | $87.5M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
NHP customer concentration
In the period ended Jun 30, 2026, a single direct customer accounted for 10% of revenue, per the company's 10-Q filed Aug 6, 2026. The company does not name it.
NHP company outlook (results filed Aug 5, 2026)
- “Note : The Company's 2026 guidance contains forward-looking statements and is based on a number of assumptions and estimates, including those identified later in this press release.”
Quoted word-for-word from the SEC 8-K results press release.
NHP analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $94.5M | — |
| Next quarter (ends Dec 2026) | — | — | — | $95.6M | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $362.5M | — |
| Next fiscal year (ends Dec 2027) | — | — | — | $354.0M | — |
Key Statistics (as of October 29, 2026 at 07:41 UTC)
| Price | USD 14.7 |
|---|---|
| Change | ▼ 1.21% (down) |
| Previous Close | USD 14.88 |
| Open | USD 14.78 |
| Day Range | USD 14.34 – 14.82 |
| 52-Week Range | USD 11.25 – 17.46 |
| Volume | 1,779,872 shares |
| Market Cap | $1.07B |
| Exchange | NGM |
Technical Analysis (NHP)
Nexqual's technical model rates NHP "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 29, 2026 at 07:41 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.23 (neutral) |
| vs SMA50 | Below (USD 15.89) |
| MACD | -0.25 (negative) |
Analyst Ratings (NHP)
Wall Street analysts rate NHP "None", per Nexqual as of October 29, 2026 at 07:41 UTC.
| Consensus Rating | None |
|---|
Earnings (NHP)
| Next Earnings Date | 2026-11-04 |
|---|---|
| Revenue Estimate | $94.52M |
Source: Nexqual, October 29, 2026 at 07:41 UTC.
Financials & Fundamentals (NHP)
| Total Revenue | $344.32M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +2.60% |
| Gross Margin | +37.88% |
| Operating Margin | +10.28% |
| Profit Margin | -13.04% |
| ROE | -5.26% |
| Debt / Equity | 0.81 |
| Current Ratio | 0.93 |
| Total Cash | $248.06M |
| Total Debt | $856.57M |
Source: Nexqual, October 29, 2026 at 07:41 UTC.
Financial Health Score (NHP)
Nexqual rates National Healthcare Properties, Inc.'s overall financial health "Weak" across five dimensions, as of October 29, 2026 at 07:41 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Weak — $248M cash vs $857M debt |
| Cash Flow | Solid — Operating cash flow $7M (FY ended Dec 2025, 10-K) |
| Efficiency | Critical — ROE -4%, ROA -2.3% (last 4 quarters, SEC) |
Ownership (NHP)
| Insider Ownership | +0.01% |
|---|---|
| Institutional Ownership | +78.17% |
| Shares Outstanding | 44.27M |
| Float | 72.74M |
| Short % of Float | +8.32% |
Source: Nexqual, October 29, 2026 at 07:41 UTC.
Leadership (NHP)
National Healthcare Properties, Inc. is led by Michael R. Anderson, President, CEO & Director, per Nexqual as of October 29, 2026 at 07:41 UTC.
| President, CEO & Director | Michael R. Anderson |
|---|---|
| CFO & Treasurer | Andrew T. Babin C.F.A. |
| Executive Vice President of Investments | Tyler Brawner |
| Director of Investor Relations | Michael Ozuna |
| Senior Vice President of Sales & Marketing | Michelle Stepinsky |
Major Backers & Investors (NHP)
Notable institutional backers of National Healthcare Properties, Inc. include Principal Funds, Inc-Real Estate Securities Fund, Fidelity, IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund, according to Nexqual as of October 29, 2026 at 07:41 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Principal Funds, Inc-Real Estate Securities Fund | 5.85% |
| Fidelity | 3.1% |
| IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund | 1.24% |
| AB EQUITY INCOME FUND INC | 1.2% |
| Prudential Investment Portfolios 12-PGIM GLOBAL REAL ESTATE FUND | 1.13% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.77% |
| BlackRock | 2.49% |
Source: Nexqual, October 29, 2026 at 07:41 UTC.
From National Healthcare Properties, Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Legal & Regulatory Risks (Item 1A, quoted)
- The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of our tenants to make rent payments to us and materially and adversely affect our operators.
- We may be subject to adverse legislative or regulatory tax changes that could increase our tax liability, reduce our operating flexibility, and reduce the value of shares of our stock.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MPT | Medical Properties Trust, Inc. | USD 2.75 | ▲ 1.1% |
| DHC | Diversified Healthcare Trust | USD 7.8 | ▲ 0.52% |
| UHT | Universal Health Realty Income | USD 36.76 | ▼ 0.14% |
| LTC | LTC Properties, Inc. | USD 42.73 | ▼ 0.42% |
| XRN | Chiron Real Estate Inc. | USD 28.77 | ▼ 0.66% |
| CHCT | Community Healthcare Trust Inco | USD 12.75 | ▼ 0.23% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 07:41 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt